Julia Marie Eastland is President at Zentalis Pharmaceuticals, Inc. (ZNTL). They have made 2 open-market trades across 1 company since 2025, most recently 2026-05-14.
CIK 0001500189
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $49K since 2025, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HARP | 269,381 | $6.2M |
| LNTH | 8,019 | $799K |
| DVAX | 16,071 | $249K |
| ZNTL | 79,133 | $170K |
| CASC | 6,160 | $62K |
| GRAY | 1,429 | $8K |
| Total | $7.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.